Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Artivion (AORT) Shares Outstanding (Weighted Average) (2016 - 2025)

Artivion (AORT) has disclosed Shares Outstanding (Weighted Average) for 9 consecutive years, with $45.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 8.78% year-over-year to $45.3 million, compared with a TTM value of $45.3 million through Dec 2025, up 8.78%, and an annual FY2025 reading of $45.3 million, up 8.78% over the prior year.
  • Shares Outstanding (Weighted Average) was $45.3 million for Q4 2025 at Artivion, down from $47.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $47.2 million in Q3 2025 and bottomed at $38.8 million in Q2 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $41.3 million, with a median of $40.7 million recorded in 2023.
  • The sharpest move saw Shares Outstanding (Weighted Average) grew 1.46% in 2023, then increased 12.88% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $39.0 million in 2021, then grew by 2.69% to $40.0 million in 2022, then grew by 1.78% to $40.7 million in 2023, then grew by 2.29% to $41.7 million in 2024, then rose by 8.78% to $45.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for AORT at $45.3 million in Q4 2025, $47.2 million in Q3 2025, and $43.3 million in Q2 2025.